Skip to content
Governance Register

← US public companies

Angiotech Pharmaceuticals INC

SEC CIK 1096481 · ANPMF · last insider filing 2012-06-25

Directors (from insider filings)

NameCapacity as filedFilings
Hunter William L Director · President and CEO filed 2008 - 2011
Willms Arthur H Director filed 2008 - 2010
Mckinnell Henry A Director filed 2008 - 2009
Howard David T Director filed 2008 - 2009
Brege Laura Director filed 2008 - 2009
Brown Edward M Director filed 2008 - 2009
Richardson Hartley T Director filed 2008 - 2009
Peet Greg Director filed 2008 - 2008

Officers (from insider filings)

NameTitle as filedFilings
Mcmasters David Sr.VP, Legal & General Counsel filed 2008 - 2011
Bailey K Thomas Chief Financial Officer filed 2008 - 2011
Neske Tammy Sr. VP Human Resources filed 2008 - 2011
Diaz Victor Manuel Sr. VP Global Manufacturing filed 2008 - 2011
Dent Jay Bernard Sr. VP Finance & Accounting filed 2008 - 2011
Gross Jeffrey M VP, Product Development filed 2008 - 2011
Bryant Steven R. SVP, Specialty Medical Device filed 2009 - 2011
Cunliffe Sean SVP, Sales & Marketing filed 2009 - 2011
Chen Jonathan W Sr.VP,BusinessDev.&FinStrategy filed 2008 - 2010
Avelar Rui Chief Medical Officer filed 2008 - 2010
Dennis Christopher John Wesley VP, Commercial Operations filed 2008 - 2009
Walker Jeffrey Paul Chief Scientific Officer filed 2008 - 2008
Hall David M Chief Compliance Officer filed 2008 - 2008

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.